Skip to main content
HeartCited

Berberine के लिए Metabolic Syndrome (Cardiovascular Aspects)

B संबंधित साक्ष्य कम से कम एक यादृच्छिक परीक्षण इसका समर्थन करता है, जिसके परिणाम अधिकतर सुसंगत हैं।

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dberberine\u0026condition\u003Dmetabolic\u002Dsyndrome\u002Dcardiovascular'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

B

निष्कर्ष

Improves multiple metabolic parameters: glucose, lipids, BMI, waist circumference. AMPK activation addresses insulin resistance — the core driver of metabolic syndrome.

Key Study Findings

Other 6 weeks
Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila.
Dose: None बनाम: MCD diet MASH model; Abx + FMT experiments Outcome: Hepatic/colonic inflammation, Akkermansia abundance प्रभाव: None None

जनसंख्या: MCD diet-induced MASH C57BL/6J male mice

Other
The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with …
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: None

Systematic Review n=61
Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review.
Dose: None बनाम: None Outcome: None प्रभाव: None None

जनसंख्या: Alzheimer's disease patients

Key Statistics

20

अध्ययन

2500

प्रतिभागी

Positive

B

ग्रेड

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

सामान्य रूप से उपयोग की जाने वाली खुराकें

general:
500-1,500 mg/day divided TID
lipidsupport:
500 mg TID with meals

अधिकतम सीमा: Not formally established; GI side effects limit doses >1,500 mg/day

अनुसंधान में अध्ययन की गई खुराकें

खुराक अवधि प्रभाव N
None 6 weeks Positive --
None -- Mixed --
None -- Positive 61

सेवन का सर्वोत्तम समय: With meals, divided TID for sustained plasma levels; short half-life

Safety & Side Effects

रिपोर्ट किए गए दुष्प्रभाव

  • Diarrhea (most common, usually resolves in 2 weeks)
  • Constipation
  • Flatulence
  • Abdominal pain
  • May lower blood sugar (monitor in diabetics)

ज्ञात अंतःक्रियाएँ

  • Metformin (additive blood sugar lowering; may increase metformin levels)
  • CYP2D6 and CYP3A4 substrates (berberine is a CYP inhibitor)
  • Cyclosporine (may increase blood levels)
  • Macrolide antibiotics (may prolong QT interval)
  • Statins (complementary mechanism; monitor for additive effects)

सहनीय अधिकतम सेवन: Not formally established; GI side effects limit doses >1,500 mg/day

कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।

Frequently Asked Questions

Does Berberine help with Metabolic Syndrome (Cardiovascular Aspects)?
Based on 20 studies with 2,500 participants, there is moderate evidence from clinical studies that Berberine may support Metabolic Syndrome (Cardiovascular Aspects) management. Our evidence grade is B (Good Evidence).
How much Berberine should I take for Metabolic Syndrome (Cardiovascular Aspects)?
Studies have used various dosages. A commonly studied range is 500-1,500 mg/day divided TID. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of Berberine?
Reported side effects may include Diarrhea (most common, usually resolves in 2 weeks), Constipation, Flatulence, Abdominal pain. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for Berberine and Metabolic Syndrome (Cardiovascular Aspects)?
We rate the evidence as Grade B (Good Evidence). This rating is based on 20 peer-reviewed studies with 2,500 total participants. The overall direction of effect is positive.

Berberine अन्य स्वास्थ्य स्थितियों के लिए

References

  1. [1] Jiahui Xu et al.. J Nutr Biochem. 2025. Berberine alleviates metabolic dysfunction-associated steatohepatitis by enhancing the abundance of Akkermansia muciniphila. doi:10.1016/j.jnutbio.2025.110069 PubMed
  2. [2] Yufan Dai et al.. Braz J Med Biol Res. 2022. The combination of berberine and evodiamine ameliorates high-fat diet-induced non-alcoholic fatty liver disease associated with modulation of gut microbiota in … doi:10.1590/1414-431X2022e12096 PubMed
  3. [3] Noriko Shinjyo et al.. J Integr Med. 2020. Berberine for prevention of dementia associated with diabetes and its comorbidities: A systematic review. doi:10.1016/j.joim.2020.01.004 PubMed

FDA अस्वीकरण: इन कथनों का Food and Drug Administration द्वारा मूल्यांकन नहीं किया गया है। इस वेबसाइट पर उत्पादों और जानकारी का उद्देश्य किसी बीमारी का निदान, उपचार, इलाज या रोकथाम नहीं है। प्रस्तुत साक्ष्य ग्रेड प्रकाशित पीयर-रिव्यूड अनुसंधान के हमारे विश्लेषण पर आधारित हैं और चिकित्सा सलाह नहीं हैं। कोई भी सप्लीमेंट शुरू करने से पहले हमेशा अपने स्वास्थ्य सेवा प्रदाता से परामर्श करें।